Table 3.

AMT-based nanomaterial drug delivery system.

Drug Carrier	Modification Methods	Zeta Potential
poly(propylene imine) (PPI) [111]	Oligosaccharide-modified	Positively charged
Poly(ethylenimine) (PEI) [35]	Conjugating with rabies virus glycoprotein and PEG	Relatively neutral
Maltodextrin nanoparticles [112]	\	25 ± 1.5
PEG-g-chitosan [105]	Transferrin receptor monoclonal antibodies (OX26)	23.0 ± 0.4
Solid lipid nanoparticles (SLNs) [109,110]	Conjugating bovine serum albumin	10.3 ± 0.6
Pluronic-based nano-carrier [106]	Chitosan and rabies virus glycoprotein-conjugated	12.1 ± 0.8